ClinicalTrials.gov
ClinicalTrials.gov Menu

A Comparison Study of LY2140023 and Aripiprazole in Schizophrenia Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01328093
Recruitment Status : Terminated (The decision to stop the trial was based on efficacy results in the overall schizophrenia participant population.)
First Posted : April 4, 2011
Last Update Posted : January 21, 2013
Sponsor:
Information provided by (Responsible Party):
Eli Lilly and Company

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : October 2012
  Actual Study Completion Date : October 2012
  Certification/Extension First Submitted : January 11, 2013